Chlormadinone acetate as an oral contraceptive.

  • Alahari Papa Rao
  • Published 1970 in Journal of obstetrics and gynaecology of India


185 women received chlormadinone acetate (a 19-hydroxyprogesterone derivative) .5 mg daily, for 18 months. All (aged 20-40 years) were parous. 180 women were followed through 2280 cycles. Dropout rate was highest in the first cycle (44%), 4% from the sixth to the twelfth cycles, and about 1% after the thirteenth cycle. Side effects were 2%: breakthrough… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.